Articles On Cann Group (ASX:CAN)

This year was a difficult one for ASX cannabis shares as well as cannabis stocks globally with share prices worldwide retreating from previous highs. In Australia the medical marijuana industry remains in its infancy. Nonetheless, the init...

There are many reasons why a company might change its name, from being taken over to hiding a shady past. This year 114 companies have changed their name. Family cyber security provider Wangle Technologies became the much more fitting Famil...

In afternoon trade the S&P/ASX 200 index is having a subdued day of trade ahead of the Christmas break. At the time of writing the benchmark index is flat at 6,785.8 points. Four shares that are performing much better are listed below....

Marijuana is the hottest herb on the planet right now, but while investing in medical cannabis stocks could make you a fortune, it could also risk the house. After a flurry of activity on the ASX in 2017 as the sector kicked off following l...

There is a lot of optimism surrounding the outlook for the multi-billion-dollar global cannabis industry, which may not be still evident from the share prices but increasing number of nations are now introducing proper legal framework to ba...

Cannabis industry is booming at a rapid pace, with several governments creating opportunities for investors by legalising recreational and medicinal cannabis. With increasing legalisation of cannabis, number of investors and entrepreneurs j...

The AusCann Group Holdings Ltd (ASX: AC8) share price certainly was out of form on Thursday. The medicinal cannabis company’s shares were the worst performers on the All Ordinaries with a decline of 13% to 23.5 cents. Why did the AusCann s...

In afternoon trade the S&P/ASX 200 index is on course to finish the day lower. At the time of writing the benchmark index is down 0.1% to 6,843.6 points. Four shares that have not let that hold them back today are listed below. Here’s...

Cann Global (ASX:CGB) has become the second small cap to enter the African cannabis market. It is a market that is estimated to reach $7.1 billion by 2023 although is only legal in three countries including South Africa, Zimbabwe and Lesoth...

Cann Group (ASX: CAN) has confirmed the first commercial medicinal cannabis product to be made at Cann’s Australian-based cultivation operations has been packed by IDT Australia (ASX: IDT) in preparation for commercial release in the new ye...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

In morning trade the Cann Group Ltd (ASX: CAN) share price is rocketing higher. At the time of writing the cannabis company’s shares are up 20% to 51 cents. Why is the Cann Group share price rocketing higher? Investors have been buying Can...

There’s no doubt 2019 has been a difficult year for ASX cannabis shares. Many of the ASX-listed producers have struggled to climb higher and, in many cases, have experienced heavy losses. So is there hope for long-term investors in the Aus...

The Australian share market may have a record high in its sights, but not all shares have been performing as strongly. Three ASX shares that have come under significant pressure this year are listed below. Here’s why they have just hit 52-...

In the global medical cannabis market scenario, Australian cannabis market is the fastest one growing in leaps and bounds. The use of cannabis as a pharmaceutical product for the therapy in severe medical conditions such as Alzheimer’s dise...

The S&P/ASX 200 index has followed the lead of U.S. markets and is dropping lower today. At the time of writing the benchmark index is down 0.15% to 6,719.8 points. Four shares that have fallen more than most today are listed below. He...

Viagra mouth spray maker SUDA Pharmaceuticals (ASX:SUD) has talked a multi-billion dollar pharmaceutical company into backing its tech. Sanofi-Aventis has signed a feasibility agreement to test the mouth spray technology with one of its own...

A significant progress has been seen in Cannabis industry at a global scale, a sector that has witnessed traction and speculation at the same time. Once, a topic of taboo, cannabis is one of the most debated topics worldwide currently.  Can...

Cannabis remains to be a subject of high speculation across the globe, even though significant advancement has been made in this field. A topic of taboo once, cannabis currently is one of the most discussed business opportunities globally,...

Cannabis space is evolving at a rapid pace with Cannabis legalisation changing the landscape across the globe. Cannabis industry is gaining investors attention despite economic pressures, market recklessness and strong competition. Cannabis...

The S&P/ASX 200 index has given back the majority of its morning gains and is trading just a fraction higher this afternoon. At the time of writing the benchmark index is up slightly at 6,868.6 points. Four shares that have failed to f...

Cannabis shares have continued their bumpy ride in November. Marijuana shares globally are trading well down from previous highs, which has impacted our ASX marijuana shares.  The intoxication that greeted the sector earlier this year has...

In the year 2019, marijuana stocks were among the hot picks for investors, despite the general market impulsiveness, strong competition and economic pressures. Recently, a green signal has been given to a bill legalising marijuana on the st...

In afternoon trade the S&P/ASX 200 index is continuing its positive run and looks set to record another solid gain. At the time of writing the benchmark index is up 0.8% to 6,783 points. Four shares that are climbing more than most tod...

The MGC Pharmaceuticals Ltd (ASX: MXC) share price has been a positive performer on Tuesday. In morning trade the cannabis company’s shares are up 3% to 3.5 cents. Why is the MGC Pharma share price charging higher? Investors have been buyi...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

In afternoon trade the S&P/ASX 200 index is fighting hard and pushing higher. At the time of writing the benchmark index is up 0.2% to 6,781 points. Four shares that have failed to follow the market higher today are listed below. Here’...

Lately, cannabis stocks in the US have come under pressure, following the rising death toll from vaping that reached 42 so far in 2019, according to media reports. Meanwhile, in Canada, Canopy Growth unveiled that returned cannabis oil prod...

The market may be trading lower today, but one group of shares is falling more than most – the cannabis companies. In early afternoon trade the cannabis industry is a sea of red as investors head for the exits in their droves. Here’s a sum...

Cannabis is a dynamic and rapidly growing sector with strong growth prospects. Countries like Canada, Germany, Norway, Thailand, Chile, Argentina, and Greece have legalised the use of medicinal cannabis, after recognizing its possible benef...

In morning trade the Althea Group Holdings Ltd (ASX: AGH) share price has raced higher following the release of an update. At the time of writing the cannabis company’s shares are up 7% to 51 cents. Why is the Althea share price on a high...

Cannabis Industry The Australian cannabis industry is the newest and the most dynamic sector after the legalization of cannabis for medicinal as well as recreational purposes. The cannabis industry refers to the activities and all the profe...

For the first time, England’s NHS approved the use of cannabis medicines to treat epilepsy and multiple sclerosis. And the industry is now pushing for CBD and THC to be allowed to be prescribed in more cases. The timing is curious, only a f...

The number of Australian patients being subscribed medicinal cannabis has risen a gigantic 1,191 per cent year-on-year, according to new data. Some 14,357 patients were approved medicinal cannabis, compared with 1,112 this time last year, a...

It ain’t easy bein’ green at the moment: more than 70 per cent of ASX-listed pot stocks have lost value so far in the 2020 financial year, a Stockhead analysis has found. The dire statistics fall against a wider backdrop of malaise in the g...

Pot stock Cann Group (ASX:CAN) has “moved into the commercialisation phase” — but it’s with imported products, as it continues to wait for approval for its own products from Australian regulators. Shares in Cann Group closed at $1.01 yester...

More than 20,000 Australians have been approved to use medical cannabis to treat conditions including cancer pain, chemotherapy-induced vomiting, drug-resistant epilepsy and anorexia

Marijuana stocks or pot stocks are catching investors’ eyes these days after the legalisation of cannabis for medicinal and recreational use in many countries.  According to the Australian health department, all the cannabis formulations su...

One of Australia's leading medicinal cannabis companies has all its ducks lined up in a row. Melbourne-based Cann Group (ASX: CAN) has today announced the signing of a nationwide distribution deal with healthcare services and products sup...

The Cann Group Ltd (ASX: CAN) share price is having a rare positive day of trade. In morning trade the cannabis company’s shares are up 4% to $1.05. This has reduced its one-month decline to approximately 30%. Why is the Cann Group share p...

Cannabis Shares Valuing a cannabis company is becoming an increasingly difficult task. Lately, the cannabis shares have been taking a beat in the domestic markets, falling from their respective all-time highs. The table below provides you w...

ASX cannabis shares have fallen out of favour recently, with the Althea Group (ASX: AGH), Cann Group Ltd (ASX: CAN) and Elixinol Global Ltd (ASX: EXL) share prices all tumbling to new lows. However, there is one cannabis share that has...

Each Monday, Stockhead recaps which stocks are most heavily in demand by investors — running hot. The analysis is based on the Relative Strength Index (RSI), a technical gauge which measures how trading momentum is affecting the price actio...

It’s been a year of highs and lows for cannabis shares. Marijuana shares were favourites of investors earlier this year but have since suffered setbacks: the vaping crisis in the United States (US) as well as issues on the home front have...

ASX cannabis stock Cann Global Ltd  (ASX: CGB) has seen its share price rocket 8.70% higher today after a key announcement. What is Cann Global? Formerly Queensland Bauxite Limited, the company has undergone significant changes in recent y...

Given it’s chock full of omega acids and other goodies, hemp is acknowledged as one of nature’s finest super foods. But how much of a good thing is too much? The issue has been occupying the collective minds of the US Food and Drug Administ...

In order to boost their returns, investors usually tend to search for stocks of the companies that are likely to report relatively higher revenues and earnings in the future. The stocks that are expected to grow substantially above the aver...

In order to boost their returns, investors usually tend to search for stocks of the companies that are likely to report relatively higher revenues and earnings in the future. The stocks that are expected to grow substantially above the aver...

Althea Group Holdings Ltd (ASX:AGH) shares are in a trading halt pending an announcement, with rumours swirling that major shareholder and supplier Aphria is looking to sell their stake in the Australia marijuana supplier. Althea shares ha...

Amidst the global market fickleness, competition and economic pressure, cannabis stocks stand out as the hot pick stocks for investors.  The Cannabis stocks are gaining traction with the sector growing at a fast pace with new listings and i...